Alunbrig is a Oral Tablet, Film Coated in the Human Prescription Drug category. It is labeled and distributed by Takeda Pharmaceuticals America, Inc.. The primary component is Brigatinib.
Product ID | 63020-090_016a4a8c-c47c-49a2-b38f-439eebc4c466 |
NDC | 63020-090 |
Product Type | Human Prescription Drug |
Proprietary Name | Alunbrig |
Generic Name | Brigatinib |
Dosage Form | Tablet, Film Coated |
Route of Administration | ORAL |
Marketing Start Date | 2017-04-28 |
Marketing Category | NDA / NDA |
Application Number | NDA208772 |
Labeler Name | Takeda Pharmaceuticals America, Inc. |
Substance Name | BRIGATINIB |
Active Ingredient Strength | 90 mg/1 |
Pharm Classes | Cytochrome P450 3A Inducers [MoA], Kinase Inhibitor [EPC], Tyrosine Kinase Inhibitors [MoA] |
NDC Exclude Flag | N |
Listing Certified Through | 2023-12-31 |
Marketing Start Date | 2017-10-02 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | NDA |
Application Number | NDA208772 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 2017-10-02 |
Marketing Category | NDA |
Application Number | NDA208772 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 2017-10-02 |
Ingredient | Strength |
---|---|
BRIGATINIB | 90 mg/1 |
SPL SET ID: | 0fe9ff20-d402-41f3-bc1e-7002ea7007db |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI |
NDC | Brand Name | Generic Name |
---|---|---|
63020-090 | Alunbrig | brigatinib |
63020-113 | Alunbrig | brigatinib |
63020-180 | Alunbrig | brigatinib |
63020-198 | Alunbrig | brigatinib |
76189-113 | Alunbrig | Brigatinib |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
ALUNBRIG 86797024 5251769 Live/Registered |
ARIAD Pharmaceuticals, Inc. 2015-10-23 |